Induced pluripotent stem cells (iPSCs) in the modeling of hepatitis C virus infection

Current Stem Cell Research and Therapy

Volumn 10, Issue 3, 2015, Pages 216-219

  Cheng, Lin ^a   Zhang, Yong ^b   Nan, Yuemin ^c   Qiao, Liang ^d  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Second People's Hospital of Lanzhou City   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Disease modeling; Hepatitis C virus; Hepatocellular carcinoma; Induced pluripotent stem cells; iPSCs; Liver transplantation

Indexed keywords

ALBUMIN; CD81 ANTIGEN; CLAUDIN 1;

ACUTE LIVER FAILURE; ARTICLE; CELL MATURATION; END STAGE LIVER DISEASE; HEMATOPOIETIC STEM CELL; HEPATITIS C; HUMAN; IN VITRO STUDY; LIFE CYCLE; LIVER CELL; LIVER FUNCTION; MACACA NEMESTRINA; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TROPISM; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; HEPACIVIRUS; NUCLEAR REPROGRAMMING; PHYSIOLOGY; STEM CELL TRANSPLANTATION; VIROLOGY;

ANIMALS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84928957000     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X09666140923121234     Document Type: Article

References (32)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
2. Ebben JD, Zorniak M, Clark PA, Kuo JS. Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine. World Neurosurg 2011; 76(3-4): 270-5.
3. Wilmut I. Consternation and confusion following EU patent judgment. Cell Stem Cell 2011; 9(6): 498-9.
4. Brown RS. Hepatitis C and liver transplantation. Nature 2005; 436(7053): 973-8.
5. Zeisel MB, Barth H, Schuster C, Baumert TF. Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy. Front Biosci 2009; 14: 3274-85.
6. Kohaar I, Ploss A, Korol E, et al.Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry. J Virol 2010; 84(14): 6987-94.
7. Marks KM, Jacobson IM. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir. Antivir Ther 2012; 17(6 Pt B): 1119-31.
8. Bukh J. Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology 2012; 142(6): 1279-8773.
9. Si-Tayeb K, Duclos-Vallee JC, Petit MA. Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal. J Hepatol 2012; 57(3): 689-91.
10. Sourisseau M, Goldman O, He W, et al.Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection. Gastroenterology 2013; 145(5): 966-967.
11. Rashid ST, Corbineau S, Hannan N, et al.Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010; 120(9): 3127-36.
12. Yusa K, Rashid ST, Strick-Marchand H, et al.Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011; 478(7369): 391-4.
13. Takebe T, Sekine K, Enomura M, et al.Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013; 499(7459): 481-4.
14. Takebe T, Zhang RR, Koike H, et al.Generation of a vascularised and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc 2014; 9(2): 396-409.
15. Song Z, Cai J, Liu Y, et al.Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009; 19(11): 1233-42.
16. Sullivan GJ, Hay DC, Park IH, et al.Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010; 51(1): 329-35.
17. Ghodsizadeh A, Taei A, Totonchi M, et al.Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev 2010; 6(4): 622-32.
18. Liu H, Kim Y, Sharkis S, Marchionni L, Jang YY. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Trans Med 2011; 3(82): 82-139.
19. Choi SM, Kim Y, Liu H, Chaudhari P, Ye Z, Jang Y-Y. Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle 2011; 10(15): 2423-7.
20. Si-Tayeb K, Noto FK, Nagaoka M, et al.Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51(1): 297-305.
21. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY. Generation of endodermderived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010; 51(5): 1810-9.
22. Chen YF, Tseng CY, Wang HW, Kuo HC, Yang VW, Lee OK. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology 2012; 55(4): 1193-203.
23. Schwartz RE, Trehan K, Andrus L, et al.Modeling hepatitis C virus infection using human induced pluripotent stem cells. P Natl Acad Sci USA 2012; 109(7): 2544-8.
24. Yoshida T, Takayama K, Kondoh M, et al.Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. Biochem Bioph Rese Co 2011; 416(1-2): 119-24.
25. Wu X, Robotham JM, Lee E, et al.Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog 2012; 8(4): e1002617.
26. Du C, Narayanan K, Leong MF, Wan AC. Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multicomponent hydrogel fibers for liver tissue engineering. Biomaterials 2014; 35(23): 6006-14.
27. Zhang Z, Liu J, Liu Y, Li Z, Gao WO, He Z. Generation, characterization and potential therapeutic applications of mature and functional hepatocytes from stem cells. J Cell Physiol 2013; 228(2): 298-305.
28. Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008; 26(5): 1117-27.
29. Khurana S, Mukhopadhyay A. Hematopoietic progenitors from early murine fetal liver possess hepatic differentiation potential. Am J Pathol 2008; 173(6): 1818-27.
30. Parekkadan B, van Poll D, Suganuma K, et al.Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PloS One 2007; 2(9): e941.
31. Shi XL, Zhang Y, Gu JY, Ding YT. Coencapsulation of hepatocytes with bone marrow mesenchymal stem cells improves hepatocyte-specific functions. Transplantation 2009; 88(10): 1178-85.
32. Liu X, Newton RC, Scherle PA. Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trend Mol Med 2010; 16(1): 37-45.